甲状腺癌术中喉返神经削切与切除的系统评价与荟萃分析
该系统评价与荟萃分析比较甲状腺癌手术中喉返神经受侵时削切肿瘤与切除神经的肿瘤学和功能结局。共纳入13项回顾性队列研究532例患者。削切组复发率更低、声带活动更好、最长发声时间更长,但两组总生存和气管切开需求无差异。削切组病变分期更早,可能存在选择偏倚。
要点
- 削切组复发率更低、声带活动更好、最长发声时间更长
- 两组总生存和气管切开需求无差异
- 削切组病变分期更早,关联可能反映选择偏倚
核心结论
- 削切与更好的功能结局和更低的复发相关,且无生存差异。
- 削切患者病变分期更早,这些关联可能反映选择偏倚,需前瞻性研究验证。
研究设计与样本
- 遵循PRISMA指南的系统评价与荟萃分析,三位评审检索七个数据库1995至2024年的研究。
- 纳入13项回顾性队列研究,共532例患者,比较喉返神经削切与切除。
主要发现
- 两组总生存和气管切开需求无差异。
- 削切与更低的复发相关(p = 0.007)。
- 削切与更好的声带活动相关(p < 0.0001)。
- 削切与更长的最长发声时间相关(p = 0.04)。
临床怎么用
- 在喉返神经受侵的甲状腺癌手术中,削切可能改善功能结局并降低复发,但需考虑病变分期和选择偏倚。
局限性
- 纳入研究均为回顾性队列,削切患者病变分期更早,可能存在选择偏倚。
- 需要前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of recurrent laryngeal nerve (RLN) invasion by thyroid cancer remains controversial between shaving the tumor and resecting it. We compared oncological and functional outcomes of the two techniques. METHODS: Following PRISMA guidelines, three reviewers searched seven databases for studies from 1995 to 2024 comparing shaving and resection of the RLN. Outcomes explored were overall survival, recurrence, preservation of vocal cord function, maximum phonation time, and other treatment-related morbidities if provided. RESULTS: A total of 13 retrospective cohorts (532 patients) met inclusion criteria. Overall survival and tracheotomy requirements did not differ between groups. Shaving was associated with lower recurrence (p = 0.007), better vocal fold mobility (p < 0.0001), and longer maximum phonation time (p = 0.04). CONCLUSION: This analysis showed that shaving was associated with better functional outcomes and lower recurrence than resection, without a survival difference. Because shaved patients had less advanced disease, these associations may reflect selection bias; prospective studies are needed.
引用
- Tran E, Kankam J, Salehian L, et al. Shaving Versus Resection on Recurrent Laryngeal Nerve in Thyroid Cancer Surgeries: A Systematic Review and Meta-Analysis. Head Neck. 2026. PMID: 42845094. doi:10.1002/hed.70509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。